Antibodies
16 October 2013
INNATE PHARMA: presents proprietary antibody-drug conjugate technology at the World ADC Summit in San Francisco16 October 2013
Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit15 October 2013
Mersana Therapeutics Earns Milestone Payment in Fleximer-ADC Collaboration with Endo Pharmaceuticals11 October 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU)11 October 2013
Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis10 October 2013
Immunomedics Announces Termination of Agreement and Return of Worldwide Rights to Veltuzumab for All Non-Cancer Indications9 October 2013
Compugen Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Mode8 October 2013
MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (Xmab55743 October 2013
Single-Agent Ramucirumab Significantly Improves Overall Survival In Advanced Gastric Cancer Patients3 October 2013
New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity2 October 2013
Merrimack Pharmaceuticals Completes Enrollment of Neoadjuvant Phase 2 Study of MM-121 in HER2-Negative Breast Cancer30 September 2013
FDA Grants Genentech’s Perjeta Accelerated Approval for Use Before Surgery in People With HER2-Positive Early Stage Breast Cancer30 September 2013
Immunomedics Reports Updated Results of Labetuzumab-SN-38 in Metastatic Colorectal Cancer30 September 2013
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune DiseasesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports